DK1401816T3 - Fremgangsmåde til fremstilling af piperidinderivatet fexofenadin - Google Patents

Fremgangsmåde til fremstilling af piperidinderivatet fexofenadin

Info

Publication number
DK1401816T3
DK1401816T3 DK02754657T DK02754657T DK1401816T3 DK 1401816 T3 DK1401816 T3 DK 1401816T3 DK 02754657 T DK02754657 T DK 02754657T DK 02754657 T DK02754657 T DK 02754657T DK 1401816 T3 DK1401816 T3 DK 1401816T3
Authority
DK
Denmark
Prior art keywords
fexofenadine
preparing
piperidine derivative
piperidine
derivative
Prior art date
Application number
DK02754657T
Other languages
Danish (da)
English (en)
Inventor
Collin Schroeder
Ryan Huddleston
Richard Charles
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1401816T3 publication Critical patent/DK1401816T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK02754657T 2001-06-15 2002-06-12 Fremgangsmåde til fremstilling af piperidinderivatet fexofenadin DK1401816T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29839701P 2001-06-15 2001-06-15
PCT/EP2002/006424 WO2002102776A1 (en) 2001-06-15 2002-06-12 Process for the production of the piperidine derivative fexofenadine

Publications (1)

Publication Number Publication Date
DK1401816T3 true DK1401816T3 (da) 2008-06-09

Family

ID=23150325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02754657T DK1401816T3 (da) 2001-06-15 2002-06-12 Fremgangsmåde til fremstilling af piperidinderivatet fexofenadin

Country Status (23)

Country Link
US (2) US6743941B2 (ja)
EP (1) EP1401816B1 (ja)
JP (1) JP4344230B2 (ja)
KR (1) KR100903285B1 (ja)
CN (1) CN1229347C (ja)
AR (1) AR037005A1 (ja)
AT (1) ATE386021T1 (ja)
AU (1) AU2002320847B2 (ja)
BR (1) BR0210410A (ja)
CA (1) CA2450313C (ja)
DE (1) DE60225008T2 (ja)
DK (1) DK1401816T3 (ja)
ES (1) ES2298384T3 (ja)
HK (1) HK1063795A1 (ja)
HU (1) HUP0401125A2 (ja)
IL (2) IL159304A0 (ja)
MX (1) MXPA03010960A (ja)
NO (1) NO20035572L (ja)
NZ (1) NZ530153A (ja)
PL (1) PL364369A1 (ja)
PT (1) PT1401816E (ja)
WO (1) WO2002102776A1 (ja)
ZA (1) ZA200308697B (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498345B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US7498443B2 (en) * 2004-09-17 2009-03-03 Albany Molecular Research, Inc. Process for production of carebastine
CN100453522C (zh) * 2005-01-26 2009-01-21 中国科学技术大学 4-[4-(1-乙氧基酰基-1-甲基乙基苯)]-4-氧代丁酸的制备方法
WO2007135693A2 (en) * 2006-05-18 2007-11-29 Ind-Swift Laboratories Limited Intermediates useful for the preparation of antihistaminic piperidine derivative
ITMI20061491A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
ITMI20061492A1 (it) * 2006-07-27 2008-01-28 Archimica Srl Processo per la preparazione di fexofenadina.
CN102070490B (zh) * 2009-11-21 2014-07-30 浙江华海药业股份有限公司 一种非索非那定中间体2-(4-(4-羟基丁酰基)苯基)-2-甲基丙氰的制备方法
CN102070570A (zh) * 2009-11-21 2011-05-25 浙江华海药业股份有限公司 一种非索非那定中间体2-甲基-2(4-(2-氧代四氢呋喃-3-羰基)苯基)丙氰及其盐的制备方法
EP3842429B1 (en) 2015-06-15 2022-09-07 Asana BioSciences, LLC Heterocyclic inhibitors of erk1 and erk2 and their use in the treatment of cancer
CN104876853B (zh) * 2015-06-17 2017-06-16 苏州卫生职业技术学院 盐酸非索非那定的合成方法
WO2017068129A1 (en) 2015-10-22 2017-04-27 Sanofi-Aventis Deutschland Gmbh Process for the preparation of fexofenadine and of intermediates used therein
US20230027072A1 (en) 2019-10-28 2023-01-26 Asana Biosciences, Llc Improved methods, kits, compositions and dosing regimens for the use of heterocyclic inhibitors of erk1 and erk2

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2946809A1 (de) * 1979-11-20 1981-06-11 A. Nattermann & Cie GmbH, 5000 Köln 4-phenyl-4-oxo-buttersaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel
IT1200123B (it) 1985-09-27 1989-01-05 Ind Chimica Srl Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo
EP0347123A3 (en) 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties
IT1249684B (it) 1991-07-19 1995-03-09 Sorin Biomedica Spa Epitopi della proteina env del virus dell'epatite c.
WO1993021156A1 (en) * 1992-04-10 1993-10-28 Merrell Dow Pharmaceuticals Inc. 4-diphenylmethyl piperidine derivatives and process for their preparation
DE69415319T2 (de) 1993-06-24 1999-06-10 Albany Molecular Research, Inc., Albany, N.Y. Verfahren zur herstellung von piperidinderivaten

Also Published As

Publication number Publication date
ZA200308697B (en) 2004-09-03
JP2005502603A (ja) 2005-01-27
HUP0401125A2 (hu) 2004-09-28
ES2298384T3 (es) 2008-05-16
PL364369A1 (en) 2004-12-13
HK1063795A1 (en) 2005-01-14
DE60225008D1 (de) 2008-03-27
NZ530153A (en) 2005-07-29
NO20035572L (no) 2004-02-16
IL159304A0 (en) 2004-06-01
EP1401816B1 (en) 2008-02-13
US20040198983A1 (en) 2004-10-07
DE60225008T2 (de) 2009-01-29
AU2002320847B2 (en) 2007-09-20
BR0210410A (pt) 2004-08-17
ATE386021T1 (de) 2008-03-15
WO2002102776A1 (en) 2002-12-27
US7235665B2 (en) 2007-06-26
EP1401816A1 (en) 2004-03-31
CN1229347C (zh) 2005-11-30
JP4344230B2 (ja) 2009-10-14
US6743941B2 (en) 2004-06-01
NO20035572D0 (no) 2003-12-12
KR20040010720A (ko) 2004-01-31
PT1401816E (pt) 2008-04-08
AR037005A1 (es) 2004-10-20
CN1516689A (zh) 2004-07-28
MXPA03010960A (es) 2004-02-27
US20030105329A1 (en) 2003-06-05
IL159304A (en) 2010-02-17
CA2450313C (en) 2010-08-10
KR100903285B1 (ko) 2009-06-17
CA2450313A1 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
NO20050144D0 (no) Fremgangsmate for a fremstille substituerte pyrimidiner
DK1370150T3 (da) t-trinsproces til fremstilling af tyggegummi
DK1223474T3 (da) Fremgangsmåde til fremstilling af estervoks
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1412459T3 (da) Fremgangsmåde til fremstilling af mellemdestillater
DK1161426T3 (da) Fremgangsmåde til fremstilling af furfural
DK1293507T3 (da) Fremgangsmåde til fremstilling af krystaller
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DE60302137D1 (de) Piperidinderivate
IS6897A (is) Aðferðir til að framleiða útskipt 2-(2-pýridýlmetýl)súlfinýl-1H-bensimídasól
DK1401816T3 (da) Fremgangsmåde til fremstilling af piperidinderivatet fexofenadin
ATE461175T1 (de) Neue piperidinverbindungen
IS7153A (is) Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
DK1362040T3 (da) Fremgangsmåde til fremstilling af mesylater af piperidinderivater
DK1446107T3 (da) Fremgangsmåde til fremstilling af tabletter omfattende s-adenosylmethionin
FI20010987A0 (fi) Uuttoprosessi
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
DK1503995T3 (da) Fremgangsmåde til fremstilling af substituerede phenylsulfonylurinstoffer
DK1519936T3 (da) Fremgangsmåde til fremstilling af nevirapin
ITMI20021031A1 (it) Procedimento per preparare policarbonato-polioli
DK1385806T3 (da) Ettrinsfremgangsmåde til fremstilling af trimethoxytoluen
DK1113009T3 (da) Fremgangsmåde til fremstilling af sulfonylaminocarbonyltriazolinonsalte
DK1685104T3 (da) Fremgangsmåde til fremstilling af N-substituerede phthalomider
FI20011563A (fi) Järjestely tuotantolaitosta varten